Financial Services

Accord Healthcare's launch of generic lenalidomide signals a new era of affordability for a key cancer drug, intensifying competition and lowering costs.

First-ever bedrock drilling at Copeçal West validates a 6km surface anomaly, hinting at a large-scale gold deposit in a historically rich mining region.

A major patent deal shields Esperion's flagship drugs from generics, securing future revenue but delaying cheaper options for millions of patients.

A new collaborative is launching major health services, from maternal care to mental health, to address deep-seated disparities on Chicago's Far Southside.

With its new SOC 2 Type 2 certification, Tech Foundry aims to set a new standard for secure, high-touch software development for SaaS enterprises.

Eagle Point Credit Co. slashes its dividend after reporting major losses but counters with a $100M buyback and a strategic shift beyond CLO equity.

Annexon Biosciences spotlights its novel C1q inhibitor, Vonaprument, aiming to be the first therapy to preserve vision in geographic atrophy patients.

Data care leader Stellar launches a new script-free tool, promising zero-downtime email migrations and challenging the complex, costly status quo.

Partnering with Riskified, the travel platform boosted approvals to 93%, enabling expansion and enhancing customer experience in a high-fraud region.

Facing a tech shortage & vehicle complexity, Autoshop Answers launches a national virtual training series to arm repair shops with critical new skills.

T3 Defense acquires a majority stake in a key Israeli manufacturer, a strategic move to ease production bottlenecks and strengthen the defense industrial base.

Teamsters' national president and CA's Lt. Governor join striking CSU workers, accusing the university of unlawfully withholding contractually promised raises.

Online casino Betty expands its Toronto footprint with new TFC and Argos partnerships, navigating a market defined by rapid growth and strict regulations.

Nakamoto Inc. acquires Bitcoin Magazine's parent and a key investment firm in an all-stock deal, raising questions about market influence and shareholder value.

Cyrano Therapeutics' CYR-064 shows promise in a Phase 2 study, potentially becoming the first approved drug for persistent post-viral smell loss.

With demand for freeze-drying surging, OFD adds project management veteran Danielle Grosso to its expanding leadership team to scale operations.

As Revvity execs prepare for key conferences, investors will watch for clues on AI strategy, growth guidance, and margin recovery after a mixed 2025.

In a crowded market, JETOUR is ditching spec-sheet wars for storytelling, launching a global film series to redefine its brand as a companion for life's journeys.

Provident Bank hires industry veteran Joseph A. Tammaro, Jr. to head its Middle Market Lending, signaling a strategic move to capture regional market share.

An independent board again backs the safety of BriaCell's metastatic breast cancer therapy in a pivotal Phase 3 trial, boosting hope for a new treatment.